Simultaneous vaccination against seasonal and pandemic flu provides protection against the virus without provoking significant side effects, according to a clinical study released on Monday by GlaxoSmithKline.

The research – requested by regulators and keenly awaited by governments tackling the current H1N1 “swine flu” pandemic – should ease international concern about the provision of both vaccines and help accelerate vaccination programmes.